Alzamend Neuro, Inc. sold 780 shares of Series B convertible preferred stock and warrants to purchase 780,000 shares of common stock to Ault Lending, LLC for a purchase price of $780,000. The company may sell up to $6 million of Series B stock and warrants. The company has been notified by Nasdaq that its common stock will be delisted unless it appeals the decision.